Epigenetic programming, early life nutrition and the risk of metabolic disease

Atherosclerosis

Volumn 266, Issue , 2017, Pages 31-40

  Block, Tomasz ^a   El Osta, Assam ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cardiovascular; Chromatin; Developmental programming; Diabetes; Epigenetics; Memory; Methylation

Indexed keywords

DIABETIC PATIENT; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HUMAN; HYPOTHALAMUS; INFERTILITY THERAPY; LIPID DIET; METABOLIC DISORDER; NONHUMAN; NUTRITION; NUTRITIONAL STATUS; OBESITY; PHARMACOGENETICS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROGENY; REVIEW; ANIMAL; BLOOD; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENERGY METABOLISM; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; GESTATIONAL AGE; MATERNAL NUTRITION; METABOLISM; PATHOPHYSIOLOGY; PRENATAL EXPOSURE; RISK FACTOR;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DIABETES, GESTATIONAL; DIET, HIGH-FAT; DNA METHYLATION; ENERGY METABOLISM; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HUMANS; HYPOTHALAMUS; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METABOLIC DISEASES; NUTRITIONAL STATUS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS;

EID: 85029724938     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2017.09.003     Document Type: Review

References (179)

1. The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:14 (1993), 977–986.
2. UK Prospective Diabetes Study (UKPDS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:9131 (1998), 837–853.
3. Action to Control Cardiovascular Risk in Diabetes Study, Gerstein, et al. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358:24 (2008), 2545–2559.
4. Agardh, E., et al. Genome-wide analysis of DNA methylation in subjects with type 1 diabetes identifies epigenetic modifications associated with proliferative diabetic retinopathy. BMC Med., 13, 2015, 182.
5. Aiken, C.E., Tarry-Adkins, J.L., Penfold, N.C., Dearden, L., Ozanne, S.E., Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid peroxidation in female mouse offspring exposed to an obesogenic maternal diet. FASEB J. 30:4 (2016), 1548–1556.
6. American Diabetes A, Diagnosis and classification of diabetes mellitus. Diabetes Care 32:Suppl 1 (2009), S62–S67.
7. Aoki, V.W., et al. Comparison of four media types during 3-day human IVF embryo culture. Reprod. Biomed. Online 10:5 (2005), 600–606.
8. Barker, D.J., The fetal and infant origins of adult disease. BMJ, 301(6761), 1990, 1111.
9. Barres, R., et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep. 3:4 (2013), 1020–1027.
10. Barrès, R., et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 15:3 (2012), 405–411.
11. Bell, C.G., et al. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med. Genomics, 3, 2010, 33.
12. Ben-Haroush, A., et al. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet. Med. 21:2 (2004), 103–113.
13. Binder, A.M., et al. Epigenome-wide and transcriptome-wide analyses reveal gestational diabetes is associated with alterations in the human leukocyte antigen complex. Clin. Epigenetics, 7(1), 2015, 79.
14. Binder, N.K., et al. Paternal diet-induced obesity retards early mouse embryo development, mitochondrial activity and pregnancy health. PLoS One, 7(12), 2012, e52304.
15. Binder, N.K., et al. Parental diet-induced obesity leads to retarded early mouse embryo development and altered carbohydrate utilisation by the blastocyst. Reprod. Fertil. Dev. 24:6 (2012), 804–812.
16. Bock, C., Analysing and interpreting DNA methylation data. Nat. Rev. Genet. 13:10 (2012), 705–719.
17. Bodvarsdottir, T.B., et al. Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes. Diabetologia 53:10 (2010), 2220–2223.
18. Bouchard, L., et al. Placental adiponectin gene DNA methylation levels are associated with mothers’ blood glucose concentration. Diabetes 61:5 (2012), 1272–1280.
19. Bouchard, L., et al. Leptin gene epigenetic adaptation to impaired glucose metabolism during pregnancy. Diabetes Care 33:11 (2010), 2436–2441.
20. Bouret, S.G., Role of early hormonal and nutritional experiences in shaping feeding behavior and hypothalamic development. J. Nutr. 140:3 (2010), 653–657.
21. Brasacchio, D., et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58:5 (2009), 1229–1236.
22. Calle, A., et al. Male mice produced by in vitro culture have reduced fertility and transmit organomegaly and glucose intolerance to their male offspring. Biol. Reprod., 87(2), 2012, 34.
23. Carless, M.A., et al. Genetic effects on DNA methylation and its potential relevance for obesity in Mexican Americans. PLoS One, 8(9), 2013, e73950.
24. Chalmers, J., Cooper, M.E., UKPDS and the legacy effect. N. Engl. J. Med. 359:15 (2008), 1618–1620.
25. Chambers, J.C., et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 3:7 (2015), 526–534.
26. Chen, J., et al. Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes. FASEB J. 22:10 (2008), 3581–3594.
27. Chen, Z., et al. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort. Proc. Natl. Acad. Sci. U. S. A. 113:21 (2016), E3002–E3011.
28. Choi, J.H., et al. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin. Exp. Allergy 35:1 (2005), 89–96.
29. Chong, C.R., et al. Thioredoxin-interacting protein: pathophysiology and emerging pharmacotherapeutics in cardiovascular disease and diabetes. Cardiovasc Drugs Ther. 28:4 (2014), 347–360.
30. Ciriello, G., et al. Emerging landscape of oncogenic signatures across human cancers. Nat. Genet. 45:10 (2013), 1127–1133.
31. Clarke-Harris, R., et al. PGC1alpha promoter methylation in blood at 5-7 years predicts adiposity from 9 to 14 years (EarlyBird 50). Diabetes 63:7 (2014), 2528–2537.
32. Cleary, P.A., et al. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes 55:12 (2006), 3556–3565.
33. Cooper, M.E., Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352:9123 (1998), 213–219.
34. Cooper, M.E., El-Osta, A., Epigenetics: mechanisms and implications for diabetic complications. Circ. Res. 107:12 (2010), 1403–1413.
35. D'Agostino, R.B. Jr., et al. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 27:9 (2004), 2234–2240.
36. Delahanty, L.M., et al. Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program. Diabetes Care 35:2 (2012), 363–366.
37. Denham, J., et al. Genome-wide sperm DNA methylation changes after 3 months of exercise training in humans. Epigenomics 7:5 (2015), 717–731.
38. Dixon, J.B., et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299:3 (2008), 316–323.
39. Donkin, I., et al. Obesity and bariatric surgery drive epigenetic variation of spermatozoa in humans. Cell Metab. 23:2 (2016), 369–378.
40. Duckworth, W., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360:2 (2009), 129–139.
41. Dumoulin, J.C., et al. Effect of in vitro culture of human embryos on birthweight of newborns. Hum. Reprod. 25:3 (2010), 605–612.
42. El-Osta, A., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205:10 (2008), 2409–2417.
43. El Hajj, N., et al. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes 62:4 (2013), 1320–1328.
44. Engerman, R.L., Kern, T.S., Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36:7 (1987), 808–812.
45. Fang, F., et al. Decitabine reactivated pathways in platinum resistant ovarian cancer. Oncotarget 5:11 (2014), 3579–3589.
46. Fenaux, P., et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. lancet Oncol. 10:3 (2009), 223–232.
47. Fernandez-Gonzalez, R., et al. Long-term effect of in vitro culture of mouse embryos with serum on mRNA expression of imprinting genes, development, and behavior. Proc. Natl. Acad. Sci. U. S. A. 101:16 (2004), 5880–5885.
48. Ferre, P., Foufelle, F., Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes. Metab. 12:Suppl 2 (2010), 83–92.
49. Finer, S., et al. Maternal gestational diabetes is associated with genome-wide DNA methylation variation in placenta and cord blood of exposed offspring. Hum. Mol. Genet. 24:11 (2015), 3021–3029.
50. Flavahan, W.A., et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529:7584 (2016), 110–114.
51. Frank, R.N., Diabetic retinopathy. N. Engl. J. Med. 350:1 (2004), 48–58.
52. French, C.A., Small-molecule targeting of BET proteins in cancer. Adv. Cancer Res. 131 (2016), 21–58.
53. Fu, Q., Olson, P., Rasmussen, D., Keith, B., Williamson, M., Zhang, K.K., et al. A short-term transition from a high-fat diet to a normal-fat diet before pregnancy exacerbates female mouse offspring obesity. Int. J. Obes. (Lond) 40:4 (2016), 564–572.
54. Fullston, T., et al. Diet-induced paternal obesity in the absence of diabetes diminishes the reproductive health of two subsequent generations of mice. Hum. Reprod. 27:5 (2012), 1391–1400.
55. Gæde, P., et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N. Engl. J. Med. 358:6 (2008), 580–591.
56. Gali Ramamoorthy, T., et al. Developmental programming of hypothalamic neuronal circuits: impact on energy balance control. Front. Neurosci., 9, 2015, 126.
57. Galmozzi, A., et al. Inhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissue. Diabetes 62:3 (2013), 732–742.
58. Gao, L., et al. Excessive autophagy induces the failure of trophoblast invasion and vasculature: possible relevance to the pathogenesis of preeclampsia. J. Hypertens. 33:1 (2015), 106–117.
59. Garcia-Manero, G., et al. Phase I/II study of a novel oral isotype-selective histone deacetylase (HDAC) inhibitor MGCD0103 in combination with azacitidine in patients (pts) with high-risk myelodysplastic syndrome (MDS) or acute myelogenous leukemia (AML). J. Clin. Oncol., 25(18_suppl), 2007 7062–7062.
60. Godfrey, K.M., et al. Epigenetic gene promoter methylation at birth is associated with Child's later adiposity. Diabetes 60:5 (2011), 1528–1534.
61. Goodwin, S., et al. Coming of age: ten years of next-generation sequencing technologies. Nat. Rev. Genet. 17:6 (2016), 333–351.
62. Group, A.C., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358:24 (2008), 2560–2572.
63. Haffner, S.M., et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?. JAMA 263:21 (1990), 2893–2898.
64. Hallschmid, M., et al. Obese men respond to cognitive but not to catabolic brain insulin signaling. Int. J. Obes. (Lond) 32:2 (2008), 275–282.
65. Hambiliki, F., et al. A prospective randomized sibling-oocyte study of two media systems for culturing cleavage-stage embryos-impact on fertilization rate. J. Assist. Reprod. Genet. 28:4 (2011), 335–341.
66. Hammes, H.P., et al. Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat. Invest Ophthalmol. Vis. Sci. 34:6 (1993), 2092–2096.
67. Hansen, K.D., et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43:8 (2011), 768–775.
68. Hartman, H., et al. Histone deacetylase regulates trypsin activation, inflammation, and tissue damage in acute pancreatitis in mice. Dig. Dis. Sci. 60:5 (2015), 1284–1289.
69. Heerboth, S., et al. Use of epigenetic drugs in disease: an overview. Genet. Epigenet 6 (2014), 9–19.
70. Heijmans, B.T., et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc. Natl. Acad. Sci. U. S. A. 105:44 (2008), 17046–17049.
71. Holman, R.R., et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359:15 (2008), 1577–1589.
72. Houde, A.A., et al. Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status. Epigenetics 8:12 (2013), 1289–1302.
73. Hu, F.B., et al. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 25:7 (2002), 1129–1134.
74. Huang, C., et al. Early life exposure to the 1959-1961 Chinese famine has long-term health consequences. J. Nutr. 140:10 (2010), 1874–1878.
75. Hung, T.H., et al. Autophagy in the human placenta throughout gestation. PLoS One, 8(12), 2013, e83475.
76. International Association of D, Pregnancy Study Groups Consensus P, International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:3 (2010), 676–682.
77. Ismail-Beigi, F., et al. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann. Intern Med. 154:8 (2011), 554–559.
78. Jacobsen, S.C., et al. Young men with low birthweight exhibit decreased plasticity of genome-wide muscle DNA methylation by high-fat overfeeding. Diabetologia 57:6 (2014), 1154–1158.
79. Jiang, L.Q., et al. Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. Am. J. Physiol. Endocrinol. Metab. 305:11 (2013), E1359–E1366.
80. Jones, P.A., Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13:7 (2012), 484–492.
81. Jones, P.A., et al. Targeting the cancer epigenome for therapy. Nat. Rev. Genet. 17:10 (2016), 630–641.
82. Juergens, R.A., et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov. 1:7 (2011), 598–607.
83. Kadoch, C., Crabtree, G.R., Mammalian SWI/SNF chromatin remodeling complexes and cancer: mechanistic insights gained from human genomics. Sci. Adv., 1(5), 2015, e1500447.
84. Kalderon, B., et al. Characterization of stages in development of obesity-diabetes syndrome in sand rat (Psammomys obesus). Diabetes 35:6 (1986), 717–724.
85. Kannel, W.B., McGee, D.L., Diabetes and cardiovascular disease. The Framingham study. JAMA 241:19 (1979), 2035–2038.
86. Karbiener, M., et al. Mesoderm-specific transcript (MEST) is a negative regulator of human adipocyte differentiation. Int. J. Obes. (Lond) 39:12 (2015), 1733–1741.
87. Keating, S.T., El-Osta, A., Epigenetic changes in diabetes. Clin. Genet. 84:1 (2013), 1–10.
88. Keating, S.T., El-Osta, A., Epigenetics and metabolism. Circ. Res. 116:4 (2015), 715–736.
89. Khurana, I., Kaspi, A., Ziemann, M., Block, T., Connor, T., Spolding, B., et al. DNA methylation regulate hypothalamic gene expression linking parental diet during pregnancy to the offspring's risk of obesity in Psammomys obesus. Int. J. Obes. (Lond) 40:7 (2016), 1079–1088.
90. Kilgore, M., et al. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35:4 (2010), 870–880.
91. Kim, M., et al. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One, 5(3), 2010, e9692.
92. King, A.J., The use of animal models in diabetes research. Br. J. Pharmacol. 166:3 (2012), 877–894.
93. King, B.M., The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol. Behav. 87:2 (2006), 221–244.
94. Kowluru, R.A., Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52:3 (2003), 818–823.
95. Kowluru, R.A., et al. Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J. Diabetes Complicat. 18:5 (2004), 282–288.
96. Lake, J.K., et al. Child to adult body mass index in the 1958 British birth cohort: associations with parental obesity. Arch. Dis. Child. 77:5 (1997), 376–381.
97. Laker, R.C., et al. Exercise prevents maternal high-fat diet-induced hypermethylation of the Pgc-1alpha gene and age-dependent metabolic dysfunction in the offspring. Diabetes 63:5 (2014), 1605–1611.
98. Lauenborg, J., et al. Increasing incidence of diabetes after gestational diabetes: a long-term follow-up in a Danish population. Diabetes Care 27:5 (2004), 1194–1199.
99. Lazaraviciute, G., et al. A systematic review and meta-analysis of DNA methylation levels and imprinting disorders in children conceived by IVF/ICSI compared with children conceived spontaneously. Hum. Reprod. Update 20:6 (2014), 840–852.
100. Lehnen, H., et al. Epigenetics of gestational diabetes mellitus and offspring health: the time for action is in early stages of life. Mol. Hum. Reprod. 19:7 (2013), 415–422.
101. Li, S.L., et al. Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes 55:9 (2006), 2611–2619.
102. Li, Y., et al. Exposure to the Chinese famine in early life and the risk of metabolic syndrome in adulthood. Diabetes Care 34:4 (2011), 1014–1018.
103. Lim, E.L., et al. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54:10 (2011), 2506–2514.
104. Lubbert, M., et al. Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group. Ann. Hematol. 95:2 (2016), 191–199.
105. Mack, E., et al. Prevention of insulin resistance and beta-cell loss by abrogating PKCepsilon-induced serine phosphorylation of muscle IRS-1 in Psammomys obesus. Diabetes Metab. Res. Rev. 24:7 (2008), 577–584.
106. Marumo, T., et al. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury. Am. J. Physiol. Ren. Physiol., 298(1), 2009, F133.
107. Masuyama, H., Hiramatsu, Y., Effects of a high-fat diet exposure in utero on the metabolic syndrome-like phenomenon in mouse offspring through epigenetic changes in adipocytokine gene expression. Endocrinology 153:6 (2012), 2823–2830.
108. Masuyama, H., et al. The effects of high-fat diet exposure in utero on the obesogenic and diabetogenic traits through epigenetic changes in adiponectin and leptin gene expression for multiple generations in female mice. Endocrinology 156:7 (2015), 2482–2491.
109. Matei, D., et al. Epigenetic resensitization to platinum in ovarian cancer. Cancer Res. 72:9 (2012), 2197–2205.
110. Mayer, W., et al. Demethylation of the zygotic paternal genome. Nature 403:6769 (2000), 501–502.
111. McGee, S.L., et al. Exercise-induced histone modifications in human skeletal muscle. J. Physiol. 587:Pt 24 (2009), 5951–5958.
112. Melamed, N., et al. Comparison of genome-wide and gene-specific DNA methylation between ART and naturally conceived pregnancies. Epigenetics 10:6 (2015), 474–483.
113. Minn, A.H., et al. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces beta-cell apoptosis. Endocrinology 146:5 (2005), 2397–2405.
114. Mizushima, N., Levine, B., Autophagy in mammalian development and differentiation. Nat. Cell Biol. 12:9 (2010), 823–830.
115. Mohammad, H.P., et al. A DNA hypomethylation signature predicts antitumor activity of LSD1 inhibitors in SCLC. Cancer Cell 28:1 (2015), 57–69.
116. Nathan, D.M., et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 353:25 (2005), 2643–2653.
117. Nathan, D.M., et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med. 348:23 (2003), 2294–2303.
118. Ng, S.F., et al. Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 467:7318 (2010), 963–966.
119. Nikonova, L., et al. Mesoderm-specific transcript is associated with fat mass expansion in response to a positive energy balance. FASEB J. 22:11 (2008), 3925–3937.
120. Oh, S.Y., et al. Autophagy-related proteins, LC3 and Beclin-1, in placentas from pregnancies complicated by preeclampsia. Reprod. Sci. 15:9 (2008), 912–920.
121. Orozco-Solis, R., et al. Nutritional programming in the rat is linked to long-lasting changes in nutrient sensing and energy homeostasis in the hypothalamus. PLoS One, 5(10), 2010, e13537.
122. Osmond, D.T., et al. Placental glucose transport and utilisation is altered at term in insulin-treated, gestational-diabetic patients. Diabetologia 44:9 (2001), 1133–1139.
123. Ostlund, I., et al. Gestational diabetes and preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 113:1 (2004), 12–16.
124. Pories, W.J., et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am. J. Clin. Nutr. 55:2 Suppl (1992), 582S–585S.
125. Prébet, T., et al. Outcome of high-risk myelodysplastic syndrome after azacitidine treatment failure. J. Clin. Oncol. 29:24 (2011), 3322–3327.
126. Prebet, T., et al. Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905. J. Clin. Oncol. 32:12 (2014), 1242–1248.
127. Qin, T., et al. Mechanisms of resistance to decitabine in the myelodysplastic syndrome. PLoS One, 6(8), 2011, e23372.
128. Rasool, M., et al. The role of epigenetics in personalized medicine: challenges and opportunities. BMC Med. Genomics, 8(Suppl 1), 2015 S5–S5.
129. Reddy, M.A., et al. Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 58:3 (2015), 443–455.
130. Reik, W., et al. Epigenetic reprogramming in mammalian development. Science 293:5532 (2001), 1089–1093.
131. Ren, M., et al. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J. Neurochem. 89:6 (2004), 1358–1367.
132. Rong, C., et al. DNA methylation profiles in placenta and its association with gestational diabetes mellitus. Exp. Clin. Endocrinol. Diabetes 123:5 (2015), 282–288.
133. Rönn, T., et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet., 9(6), 2013, e1003572.
134. Ross, M.G., Desai, M., Developmental programming of appetite/satiety. Ann. Nutr. Metab. 64:Suppl 1 (2014), 36–44.
135. Roy, S., et al. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc. Natl. Acad. Sci. U. S. A. 87:1 (1990), 404–408.
136. Rutti, S., et al. IL-13 improves beta-cell survival and protects against IL-1beta-induced beta-cell death. Mol. Metab. 5:2 (2016), 122–131.
137. Salomon, C., et al. Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin. PLoS One, 7(7), 2012, e40578.
138. Sapienza, C., et al. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 6:1 (2011), 20–28.
139. Schmidt-Nielsen, K., et al. Diabetes mellitus in the sand rat induced by standard laboratory diets. Science 143:3607 (1964), 689–690.
140. Schork, N.J., Personalized medicine: time for one-person trials. Nature 520:7549 (2015), 609–611.
141. Schulz, L.C., The Dutch Hunger Winter and the developmental origins of health and disease. Proc. Natl. Acad. Sci. U. S. A. 107:39 (2010), 16757–16758.
142. Sharma, S.V., et al. A chromatin-mediated reversible drug tolerant state in cancer cell subpopulations. Cell 141:1 (2010), 69–80.
143. Sidore, C., et al. Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers. Nat. Genet. 47:11 (2015), 1272–1281.
144. Signorelli, P., et al. Autophagy in term normal human placentas. Placenta 32:6 (2011), 482–485.
145. Smith, Z.D., et al. DNA methylation dynamics of the human preimplantation embryo. Nature 511:7511 (2014), 611–615.
146. Song, S., et al. DNA methylation differences between in vitro- and in vivo-conceived children are associated with ART procedures rather than infertility. Clin. Epigenetics, 7(1), 2015, 41.
147. Stanya, K.J., et al. Direct control of hepatic glucose production by interleukin-13 in mice. J. Clin. Invest 123:1 (2013), 261–271.
148. Stein, E.M., IDH2 inhibition in AML: finally progress?. Best. Pract. Res. Clin. Haematol. 28:2–3 (2015), 112–115.
149. Sturek, J.M., et al. An intracellular role for ABCG1-mediated cholesterol transport in the regulated secretory pathway of mouse pancreatic beta cells. J. Clin. Invest 120:7 (2010), 2575–2589.
150. Takahashi, M., et al. Mest/Peg1 imprinted gene enlarges adipocytes and is a marker of adipocyte size. Am. J. Physiol. Endocrinol. Metab. 288:1 (2005), E117–E124.
151. Thurner, S., et al. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century. Proc. Natl. Acad. Sci. U. S. A. 110:12 (2013), 4703–4707.
152. Tominaga, M., et al. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22:6 (1999), 920–924.
153. Tough, D.F., et al. Epigenetic drug discovery: breaking through the immune barrier. Nat. Rev. Drug Discov. 15:12 (2016), 835–853.
154. Turner, R.C., et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:21 (1999), 2005–2012.
155. van Dieren, S., et al. The global burden of diabetes and its complications: an emerging pandemic. Eur. J. Cardiovasc Prev. Rehabil. 17:Suppl 1 (2010), S3–S8.
156. Vanhees, K., et al. You are what you eat, and so are your children: the impact of micronutrients on the epigenetic programming of offspring. Cell Mol. Life Sci. 71:2 (2014), 271–285.
157. Vedtofte, L., et al. Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus. Regul. Pept. 160:1–3 (2010), 106–114.
158. Vickers, M.H., et al. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am. J. Physiol. Endocrinol. Metab. 279:1 (2000), E83–E87.
159. Walder, K.R., et al. Characterization of obesity phenotypes in Psammomys obesus (Israeli sand rats). Int. J. Exp. Diabetes Res. 1:3 (2000), 177–184.
160. Watson, P.J., et al. Nuclear hormone receptor co-repressors: structure and function. Mol. Cell Endocrinol. 348:2 (2012), 440–449.
161. Weems, J.C., et al. Class II histone deacetylases downregulate GLUT4 transcription in response to increased cAMP signaling in cultured adipocytes and fasting mice. Diabetes 61:6 (2012), 1404–1414.
162. Wells, J.C., Thrift: a guide to thrifty genes, thrifty phenotypes and thrifty norms. Int. J. Obes. (Lond) 33:12 (2009), 1331–1338.
163. Whincup, P.H., et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 300:24 (2008), 2886–2897.
164. Williams, L., et al. Animal models of in utero exposure to a high fat diet: a review. Biochim. Biophys. Acta 1842:3 (2014), 507–519.
165. Writing Team for the Diabetes C, Complications Trial/Epidemiology of Diabetes I, Complications Research G, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287:19 (2002), 2563–2569.
166. Writing Team for the Diabetes C, Complications Trial/Epidemiology of Diabetes I, Complications Research G, Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:16 (2003), 2159–2167.
167. Xella, S., et al. Embryo quality and implantation rate in two different culture media: ISM1 versus Universal IVF Medium. Fertil. Steril. 93:6 (2010), 1859–1863.
168. Yoo, T., et al. Hypermethylation of repetitive DNA elements in livers of mice fed an atherogenic diet. Nutrition 28:2 (2012), 127–130.
169. You, J.S., Jones, P.A., Cancer genetics and epigenetics: two sides of the same coin?. Cancer Cell 22:1 (2012), 9–20.
170. Young, L.E., et al. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat. Genet. 27:2 (2001), 153–154.
171. Yousheng, J., et al. Programmed alterations in hypothalamic neuronal orexigenic responses to ghrelin following gestational nutrient restriction. Reprod. Sci. 15:7 (2008), 702–709.
172. Zaina, S., et al. DNA methylation map of human atherosclerosis. Circ. Cardiovasc Genet. 7:5 (2014), 692–700.
173. Zeng, L., Zhou, M.M., Bromodomain: an acetyl-lysine binding domain. FEBS Lett. 513:1 (2002), 124–128.
174. Zhong, Q., Kowluru, R.A., Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes 60:4 (2011), 1304–1313.
175. Zhong, Q., Kowluru, R.A., Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation. Invest Ophthalmol. Vis. Sci. 54:1 (2013), 244–250.
176. Zhong, Q., Kowluru, R.A., Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 62:7 (2013), 2559–2568.
177. Zinman, B., et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373:22 (2015), 2117–2128.
178. Ziv, E., et al. Changing pattern of prevalence of insulin resistance in Psammomys obesus, a model of nutritionally induced type 2 diabetes. Metabolism 48:12 (1999), 1549–1554.
179. Zoungas, S., et al. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N. Engl. J. Med. 371:15 (2014), 1392–1406.